Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 8 of 5804
-
Spinal injection drug shows promise in stopping SMA before symptoms start
Disease control CompletedThe primary objective of the study is to examine the efficacy of multiple doses of Nusinersen administered intrathecally in preventing or delaying the need for respiratory intervention or death in infants with genetically diagnosed and presymptomatic spinal muscular atrophy (SMA)…
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Penis transplants could restore form and function for wounded warriors
Disease control Recruiting nowInjuries to the genitalia are of concern to the military with emphasis placed on the surgical reconstruction and psychological health of these Wounded Warriors. However, despite significant surgical advances in microvascular surgery and autologous free tissue transfer, convention…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Personalized leukemia vaccine aims to outsmart relapse
⭐️ CURE ⭐️ CompletedAcute myelogenous leukemia (AML) arises from leukemia stem cells that are difficult to eradicate and serve as a reservoir for disease relapse following chemotherapy. A promising area of investigation is the development of immunotherapeutic approaches that stimulate the immune sys…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ CURE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Gene therapy offers hope for children with rare brain disease
Disease control CompletedThis Phase I/II clinical trial consists of the application of lentiviral vector-based gene therapy to patients affected by Metachromatic Leukodystrophy (MLD), a rare inherited Lysosomal Storage Disorder (LSD) resulting from mutations in the gene encoding the Arylsulfatase A (ARSA…
Phase: PHASE1, PHASE2 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Supercharged immune cells take aim at cancer and viruses in one shot
⭐️ CURE ⭐️ OngoingSubjects are having a bone marrow or SCT for either a type of cancer of the blood called Leukemia or a cancer of the lymph nodes called non- Hodgkin's Lymphoma. Although a transplant can cure leukemia or lymphoma, some people will relapse. In those who relapse, current treatment …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: ⭐️ CURE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Ebola antibody cocktail made available in emergency outbreak
Disease control AVAILABLEProvide access to REGN-EB3 for the treatment of patients with Ebola Virus Disease (EVD).
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Cow-Hemoglobin infusion could save lives when blood is not an option
Disease control NO_LONGER_AVAILABLEHBOC-201 provides an oxygen treatment bridge and can be used to eliminate, delay, or reduce the need for red blood cell transfusions in anemic patients This is an expanded access IND protocol, and will provide treatment with HBOC-201 to severely anemic adults for whom blood is n…
Sponsor: Michael Boisen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Personalized vaccine aims to stop lynch syndrome cancers before they start
Prevention Not yet recruitingThe primary objective is to assess the effect of vaccination with neopeptide-loaded dendritic cells on disease-free survival (DFS) compared to placebo in LS subjects who are known to be carrier of a germline MMR-gene mutation with no signs of disease.
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Scientists harness Patients' own immune cells to attack Treatment-Resistant melanoma
Disease control Not yet recruitingThe goal of this study is to determine the activity of Perkileucel, a tumour infiltrating lymphocyte (TIL) adoptive cell transfer therapy (ACT), in patients with unresectable stage III or metastatic melanoma who have progressed on previous treatment with immune checkpoint inhibit…
Phase: PHASE2 • Sponsor: East Metropolitan Health Service, Australia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple blood and stool test slash gastrointestinal cancer deaths?
Diagnosis Recruiting nowThis study is a multicenter, randomized controlled trial. The plan is to enroll eligible participants and randomly assign them to two groups: one group will undergo testing using a combined model of "multi-target blood methylation + fecal FIT + fecal calpetin"; those with positiv…
Phase: NA • Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Triple-Attack CAR-T cells take aim at stubborn neuroblastoma
Disease control Recruiting nowThe purpose of this clinical trial is to assess the feasibility, safety and efficacy of multiple 4SCAR-T cell therapy which targets GD2, PSMA and CD276 surface antigens in patients with relapsed and refractory neuroblastoma (NB). Another goal of the study is to understand the fun…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a new combo wipe out hepatitis b for good?
⭐️ CURE ⭐️ Not yet recruitingThis is a real-world, prospective, multicenter, non-randomized, controlled study. It aims to investigate the efficacy and safety of pegylated interferon α-2b (PEG IFN α-2b) monotherapy versus its combination with nucleos(t)ide analogs (NAs) regarding hepatitis B surface antigen (…
Sponsor: xieqing • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:09 UTC
-
New RSV vaccine trial aims to shield seniors from deadly lung infections
⭐️ VACCINE ⭐️ Recruiting nowThis study will evaluate the efficacy of the Recombinant RSV vaccine(CHO cell) vaccine in preventing lower respiratory tract diseases(LRTD) caused by RSV in adults≥ 60 years of following a single dose of the RSV vaccine(CHO cell) vaccine .This study will also assess if the vaccin…
Phase: PHASE3 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowResearchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HIV-1 infection as well as or better than a standard (usual) pre-exposure prophyla…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells aim to tame lupus without daily pills
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.
Phase: PHASE2 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New mRNA vaccine aims to stop the stomach flu
⭐️ VACCINE ⭐️ OngoingThe primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prevent protocol-defined moderate or severe norovirus acute gastroenteritis (AGE) associated with vaccine matched genotypes.
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
Mass antibiotic dosing could save thousands of children in niger
Disease control Recruiting nowSeveral randomized controlled trials have demonstrated that azithromycin mass drug administration (MDA) reduces child mortality, but increases antimicrobial resistance (AMR). The World Health Organization (WHO) guidelines for this intervention specify that implementation must be …
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a stem cell transplant free kidney recipients from a lifetime of anti-rejection drugs?
Disease control Recruiting nowThe study will determine whether patients with functioning Human Leukocyte Antigen (HLA) matched kidney transplants for at least one year and who want to discontinue immunosuppressive drugs can be treated with Total Lymphoid Irradiation (TLI) and rabbit Anti-Thymocyte Globulin (r…
Phase: PHASE1 • Sponsor: Stephan Busque • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to outperform standard therapy in High-Risk breast cancer
Disease control OngoingThis study aims to Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants with Residual Invasive Disease Following Neoadjuvant Therapy,This study will examine SHR-A1811versus trastuzumab emtansine (T-DM1) in p…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental malaria vaccine aims to block parasite growth
⭐️ VACCINE ⭐️ CompletedMalaria is a major public health problem. There were around 240 million cases of malaria and 627,000 deaths worldwide in 2020. There is a great need for a safe, effective malaria vaccine and the team at University of Oxford is trying to make vaccine(s) which can prevent serious i…
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 22, 2026 00:00 UTC